AgNovos Healthcare to Present the Results of a Pre-clinical Study evaluating OSSURE in canines with a critical-size defect and treated with and without alendronate
During the 44th European Calcified Tissue Society congress in Salzburg, AgNovos will present a poster with the results of a preclinical study performed to evaluate the biological response to implantation of OSSURE in critical-sized defects and whether those responses were impacted by alendronate therapy.